Printer Ink is Found Inside 36,000 bottles of Eye Drops

2013-01-10T08:41:03-05:00

Printer Ink is Found Inside 36,000 bottles of Eye Drops Almost 36,000 bottles of prescription eye drops need to be sent back to their manufacturer, after they were found to contain printing ink. Bausch and Lomb, the maker of the drops, has sent letters to doctors and chemists ordering the return of 1,780 batches, each containing 20 bottles of the solution, which is used as a local anaesthetic for eye procedures in hospitals. A spokeswoman for the company said: “Bausch and Lomb is conducting a voluntary recall of a single lot of proxymetacaine 0.5 per cent Minims Eye Drops Solution. “We chose to initiate this recall after confirming a report of the presence of foreign particles in a product from this single lot. “No other products in the Minims range or other Bausch and Lomb products are affected by this action.” There is so far no evidence of injury to users as a result of the blunder. In a letter to hospitals and pharmacies, Irene Fazakerley, from the Scottish Government's health department, said: “Bausch and Lomb is recalling the batch because black particles have been identified in some packs. “Initial investigations suggest that the contaminant is printing ink, in which case we understand that the risk of toxicity is low. “No other batches of this or any other product are affected. “Healthcare professionals are asked to quarantine remaining stock and contact the wholesaler from which it was obtained to arrange uplift and replacement.” A spokesman from the drug watchdog, the Medicines and Healthcare products Regulatory Agency said: “These eye drops are only used in hospitals and administered by medical professionals. “We don't anticipate that people will have them at home.”

Tonernews.com, January 10, 2013. USA

This topic has 0 replies, 1 voice, and was last updated 11 years, 4 months ago by Anonymous.

Viewing 1 post (of 1 total)

Author

Posts
#5621

Anonymous
Inactive

Printer Ink is Found Inside 36,000 bottles of Eye Drops 
Almost 36,000 bottles of prescription eye drops need to be sent back to their manufacturer, after they were found to contain printing ink.
Bausch and Lomb, the maker of the drops, has sent letters to doctors and chemists ordering the return of 1,780 batches, each containing 20 bottles of the solution, which is used as a local anaesthetic for eye procedures in hospitals.
A spokeswoman for the company said: “Bausch and Lomb is conducting a voluntary recall of a single lot of proxymetacaine 0.5 per cent Minims Eye Drops Solution.
“We chose to initiate this recall after confirming a report of the presence of foreign particles in a product from this single lot.
“No other products in the Minims range or other Bausch and Lomb products are affected by this action.”
There is so far no evidence of injury to users as a result of the blunder.
In a letter to hospitals and pharmacies, Irene Fazakerley, from the Scottish Government’s health department, said: “Bausch and Lomb is recalling the batch because black particles have been identified in some packs.
“Initial investigations suggest that the contaminant is printing ink, in which case we understand that the risk of toxicity is low.
“No other batches of this or any other product are affected.
“Healthcare professionals are asked to quarantine remaining stock and contact the wholesaler from which it was obtained to arrange uplift and replacement.”
A spokesman from the drug watchdog, the Medicines and Healthcare products Regulatory Agency said: “These eye drops are only used in hospitals and administered by medical professionals.
“We don’t anticipate that people will have them at home.”
Author

January 10, 2013 at 8:41 AM

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.

The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty, or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action based on the content on our site.